AlphaFold predicted structure
MBL2 · P11226

Mean pLDDT
81.6/ 100
Confident
248 residues
Confidence breakdown
- Very high(≥ 90)55%
- Confident(70–90)17%
- Low(50–70)16%
- Very low(< 50)13%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mannose binding lectin 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Primary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalCOVID-19 research
BOTH monoallelic and biallelic, autosomal or pseudoautosomalbone fracture
COVID-19
dengue disease
complement deficiency
pernicious anemia
placental abruption
ulna fracture
radius fracture
androgenetic alopecia
Abnormal nasolacrimal system morphology
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mannose-binding protein C
Calcium-dependent lectin, which acts as a pattern recognition receptor that initiates the lectin pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:14515269, PubMed:22966085, PubMed:7634089, PubMed:9087411). Specifically recognizes and binds the mannose moiety of carbohydrates on the pathogen surface, activating the MASP1 serine protease and initiating the proteolytic cascade of the lectin complement pathway (PubMed:22966085, PubMed:2573758, PubMed:6643429, PubMed:8082295, PubMed:9087411). Upon SARS coronavirus-2/SARS-CoV-2 infection, activates the complement lectin pathway which leads to the inhibition SARS-CoV-2 infection and a reduction of the induced inflammatory response (PubMed:35102342). May bind DNA (PubMed:15145932)
MBL2 · P11226

Mean pLDDT
81.6/ 100
Confident
248 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0